[Ip-health] I-MAK Challenges Patents on Lifesaving HIV Drug Combination in Europe, India

[Tahir Amin]

--
[ Picked text/plain from multipart/alternative ]
August 16, 2007

New York =96 Today, a U.S.-based non-profit organization, the Initiative fo=
r
Medicines, Access & Knowledge (I-MAK) announced its filings of critical
patent challenges on the HIV drug combination Lopinavir/Ritonavir. This dru=
g
combination is manufactured and sold by U.S. drug company Abbott
Laboratories under the brand name Aluvia(r). I-MAK's patent submissions wer=
e
filed at the European Patent Office and the Indian Patent Office.

For more information on the filing, please visit
www.i-mak.org/i-mak-news-updates/.

For a summary of key arguments or the documents, please visit
www.i-mak.org/lopinavirritonavir.

*
* *

*


--
Tahir Amin
Initiative for Medicines, Access & Knowledge (I-MAK)
+44 771 853 9472